| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.
|
Nat Genet
|
2005
|
2.82
|
|
2
|
Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.
|
Carcinogenesis
|
2008
|
1.73
|
|
3
|
Effect of individual psychological intervention in Chinese women with gynecologic malignancy: a randomized controlled trial.
|
J Clin Oncol
|
2005
|
1.58
|
|
4
|
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
|
Proc Natl Acad Sci U S A
|
2010
|
1.50
|
|
5
|
Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
|
Carcinogenesis
|
2008
|
1.49
|
|
6
|
p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
|
Cancer Res
|
2008
|
1.38
|
|
7
|
Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
|
Am J Obstet Gynecol
|
2006
|
1.38
|
|
8
|
Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.
|
J Clin Microbiol
|
2009
|
1.37
|
|
9
|
The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues.
|
Gynecol Oncol
|
2005
|
1.36
|
|
10
|
Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
|
BMC Cancer
|
2006
|
1.34
|
|
11
|
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies.
|
Lancet Oncol
|
2009
|
1.26
|
|
12
|
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
|
Cancer Res
|
2002
|
1.23
|
|
13
|
Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review.
|
Arch Gynecol Obstet
|
2008
|
1.22
|
|
14
|
Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
|
Cancer Lett
|
2009
|
1.21
|
|
15
|
Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
|
Int J Cancer
|
2010
|
1.19
|
|
16
|
Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer.
|
Hum Mutat
|
2003
|
1.16
|
|
17
|
Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.
|
Mol Cancer
|
2009
|
1.16
|
|
18
|
Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
|
Oncotarget
|
2012
|
1.12
|
|
19
|
Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer.
|
Gynecol Oncol
|
2006
|
1.12
|
|
20
|
Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis.
|
Oncogene
|
2005
|
1.12
|
|
21
|
Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells.
|
Endocrinology
|
2006
|
1.12
|
|
22
|
Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
|
PLoS One
|
2011
|
1.11
|
|
23
|
Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.
|
Carcinogenesis
|
2008
|
1.11
|
|
24
|
Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer.
|
Gynecol Oncol
|
2003
|
1.10
|
|
25
|
Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
|
Mod Pathol
|
2004
|
1.09
|
|
26
|
iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe.
|
Clin Cancer Res
|
2011
|
1.09
|
|
27
|
Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study.
|
Gynecol Oncol
|
2003
|
1.08
|
|
28
|
Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.
|
J Mol Diagn
|
2004
|
1.05
|
|
29
|
AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
|
PLoS One
|
2013
|
1.02
|
|
30
|
Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
|
Am J Pathol
|
2008
|
1.01
|
|
31
|
Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong.
|
Prev Med
|
2007
|
1.01
|
|
32
|
Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
|
Gynecol Oncol
|
2004
|
1.01
|
|
33
|
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.
|
Oncotarget
|
2014
|
0.99
|
|
34
|
Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
|
Cancer Genet Cytogenet
|
2005
|
0.99
|
|
35
|
Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis.
|
Clin Cancer Res
|
2010
|
0.99
|
|
36
|
Aberrant activation of hedgehog signaling pathway contributes to endometrial carcinogenesis through beta-catenin.
|
Mod Pathol
|
2009
|
0.98
|
|
37
|
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population.
|
Hum Mutat
|
2002
|
0.98
|
|
38
|
Retracted
Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
|
Carcinogenesis
|
2011
|
0.98
|
|
39
|
The effect of school-based cervical cancer education on perceptions towards human papillomavirus vaccination among Hong Kong Chinese adolescent girls.
|
Patient Educ Couns
|
2010
|
0.98
|
|
40
|
Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1).
|
J Soc Gynecol Investig
|
2005
|
0.97
|
|
41
|
Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole.
|
Arch Pathol Lab Med
|
2003
|
0.96
|
|
42
|
Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer.
|
PLoS One
|
2012
|
0.96
|
|
43
|
Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.
|
J Epidemiol Community Health
|
2006
|
0.95
|
|
44
|
The use of music to reduce anxiety for patients undergoing colposcopy: a randomized trial.
|
Gynecol Oncol
|
2003
|
0.95
|
|
45
|
Estrogen receptor subtypes in ovarian cancer: a clinical correlation.
|
Obstet Gynecol
|
2008
|
0.95
|
|
46
|
Increased expression of PITX2 transcription factor contributes to ovarian cancer progression.
|
PLoS One
|
2012
|
0.94
|
|
47
|
Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
|
PLoS One
|
2012
|
0.94
|
|
48
|
Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup.
|
Int J Gynecol Cancer
|
2014
|
0.93
|
|
49
|
Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinoma.
|
Endocrinology
|
2005
|
0.93
|
|
50
|
Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
|
Cancer
|
2004
|
0.93
|
|
51
|
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.
|
J Mol Diagn
|
2005
|
0.92
|
|
52
|
Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
|
Vaccine
|
2008
|
0.92
|
|
53
|
Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.
|
Mol Cancer
|
2010
|
0.92
|
|
54
|
Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells.
|
Cancer Res
|
2008
|
0.90
|
|
55
|
Targeting GRB7/ERK/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells.
|
PLoS One
|
2012
|
0.90
|
|
56
|
Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma.
|
Reprod Sci
|
2008
|
0.89
|
|
57
|
p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
|
Am J Pathol
|
2010
|
0.88
|
|
58
|
Gestational trophoblastic disease.
|
Best Pract Res Clin Obstet Gynaecol
|
2012
|
0.88
|
|
59
|
Cervical cancer burden and prevention strategies: Asia Oceania perspective.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.87
|
|
60
|
Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.
|
Tumour Biol
|
2004
|
0.87
|
|
61
|
HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesis.
|
J Med Virol
|
2015
|
0.86
|
|
62
|
Dysregulated stemness-related genes in gynecological malignancies.
|
Histol Histopathol
|
2012
|
0.86
|
|
63
|
Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells.
|
J Pathol
|
2011
|
0.85
|
|
64
|
Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese?
|
J Public Health (Oxf)
|
2008
|
0.84
|
|
65
|
Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
|
Tumour Biol
|
2008
|
0.83
|
|
66
|
Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
|
Histopathology
|
2011
|
0.83
|
|
67
|
Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization.
|
Cancer
|
2002
|
0.81
|
|
68
|
Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers.
|
Ann N Y Acad Sci
|
2005
|
0.81
|
|
69
|
Asian society of gynecologic oncology workshop 2010.
|
J Gynecol Oncol
|
2010
|
0.81
|
|
70
|
Staging of uterine sarcomas.
|
Best Pract Res Clin Obstet Gynaecol
|
2011
|
0.81
|
|
71
|
De-stigmatising human papillomavirus in the context of cervical cancer: a randomised controlled trial.
|
Psychooncology
|
2010
|
0.81
|
|
72
|
Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
|
Clin Cancer Res
|
2005
|
0.80
|
|
73
|
Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
|
Cancer
|
2005
|
0.79
|
|
74
|
Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
|
Acta Obstet Gynecol Scand
|
2011
|
0.79
|
|
75
|
Assessment of knowledge and stigmatizing attitudes related to human papillomavirus among Hong Kong Chinese healthcare providers.
|
Int J Gynaecol Obstet
|
2011
|
0.79
|
|
76
|
Association of ICAM3 genetic variant with severe acute respiratory syndrome.
|
J Infect Dis
|
2007
|
0.79
|
|
77
|
Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
|
Mod Pathol
|
2010
|
0.79
|
|
78
|
Screening for HIV infection in women with newly diagnosed cervical cancer.
|
Gynecol Oncol
|
2004
|
0.78
|
|
79
|
Comparison of the GenoFlow human papillomavirus (HPV) test and the Linear Array assay for HPV screening in an Asian population.
|
J Clin Microbiol
|
2012
|
0.78
|
|
80
|
Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
|
Carcinogenesis
|
2013
|
0.78
|
|
81
|
Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor.
|
Mitochondrion
|
2006
|
0.77
|
|
82
|
Human female reproductive tract epithelial cell culture.
|
Methods Mol Biol
|
2013
|
0.77
|
|
83
|
Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix.
|
Gynecol Oncol
|
2004
|
0.77
|
|
84
|
Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.
|
Cancer
|
2005
|
0.77
|
|
85
|
Human papillomavirus vaccine: what are women most concerned about?
|
J Obstet Gynaecol Res
|
2011
|
0.77
|
|
86
|
Detection of mitochondrial DNA mutations in gestational trophoblastic disease.
|
Hum Mutat
|
2003
|
0.76
|
|
87
|
Hepatic arteriogram for gestational trophoblastic tumor: is it useful?
|
Cancer Invest
|
2005
|
0.75
|
|
88
|
Apoptotic and proliferative activity in ovarian benign, borderline and malignant tumors.
|
Chin Med Sci J
|
2002
|
0.75
|
|
89
|
Preface. Uterine sarcoma.
|
Best Pract Res Clin Obstet Gynaecol
|
2011
|
0.75
|
|
90
|
Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor.
|
Int J Gynecol Pathol
|
2010
|
0.75
|
|
91
|
c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
|
Int J Gynecol Pathol
|
2004
|
0.75
|